Published Studies Related to Lithium Citrate
Well-designed clinical trials related to Lithium Citrate
A 12-week, open, randomized trial comparing sodium valproate to lithium in patients with bipolar I disorder suffering from a manic episode. [2008.09]
Lithium-induced nephrogenic diabetes insipidus: renal effects of amiloride. [2008.09]
The Collaborative Lithium Trials (CoLT): specific aims, methods, and implementation. [2008.08.12]
A double-blind, randomized, placebo-controlled 4-week study on the efficacy and safety of the purinergic agents allopurinol and dipyridamole adjunctive to lithium in acute bipolar mania. [2008.08]
A Double-Blind, Randomized, Placebo-Controlled 4-Week Study on the Efficacy and Safety of the Purinergic Agents Allopurinol and Dipyridamole Adjunctive to Lithium in Acute Bipolar Mania. [2008.07.29]
Lithium-induced Nephrogenic Diabetes Insipidus: Renal Effects of Amiloride. [2008.07.02]
A double-blind, randomized, placebo-controlled prophylaxis trial of oxcarbazepine as adjunctive treatment to lithium in the long-term treatment of bipolar I and II disorder. [2008.06]
Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: A randomized, parallel group, open-label trial. [2008.05.15]
Serotonin transporter gene and response to lithium augmentation in depression. [2008.04]
Comparison of Short-Term Venlafaxine Versus Lithium Monotherapy for Bipolar II Major Depressive Episode: A Randomized Open-Label Study. [2008.04]
Olanzapine or lamotrigine addition to lithium in remitted bipolar disorder patients with anxiety disorder comorbidity: a randomized, single-blind, pilot study. [2008.04]
What is the optimal serum lithium level in the long-term treatment of bipolar disorder--a review? [2008.03]
Response and remission rates in Chinese patients with bipolar mania treated for 4 weeks with either quetiapine or lithium: a randomized and double-blind study. [2008.01]
Olanzapine versus lithium in the acute treatment of bipolar mania: A double-blind, randomized, controlled trial. [2008.01]
FDG-PET study in pathological gamblers. 1. Lithium increases orbitofrontal, dorsolateral and cingulate metabolism. [2008]
Initial symptoms of manic relapse in manic or mixed-manic bipolar disorder: post hoc analysis of patients treated with olanzapine or lithium. [2007.10]
Lithium augmentation compared with phenelzine in treatment-resistant depression in the elderly: an open, randomized, controlled trial. [2007.08]
A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania. [2007.07]
Lithium versus lamotrigine augmentation in treatment resistant unipolar depression: a randomized, open-label study. [2007.05]
Are serum lithium levels related to the polarity of recurrence in bipolar disorders? Evidence from a multicenter trial. [2007.05]
Valproate or olanzapine add-on to lithium: an 8-week, randomized, open-label study in Italian patients with a manic relapse. [2007.04]
Quetiapine augmentation of treatment-resistant depression: a comparison with lithium. [2007.02]
Serum lithium concentration can be used to assess dietary compliance in adults. [2004.11]
Oral choline decreases brain purine levels in lithium-treated subjects with rapid-cycling bipolar disorder: a double-blind trial using proton and lithium magnetic resonance spectroscopy. [2003.08]
Endocrine effects of lithium carbonate in healthy premenopausal women: relationship with body weight regulation. [2000.01]
Acute mania: haloperidol dose and augmentation with lithium or lorazepam. [1999.12]
Treatment of manic episodes: zuclopenthixol and clonazepam versus lithium and clonazepam. [1996.02]
Effect of sodium polystyrene sulfonate on lithium bioavailability. [1992.11]
Lithium absorption prevented by sodium polystyrene sulfonate in volunteers. [1992.11]
Bioavailability of lithium from lithium citrate syrup versus conventional lithium carbonate tablets. [1992.10]
Two regimens of lithium prophylaxis and renal function. [1989.12]
Sodium, lithium-countertransport and blood pressure control by nutritional intervention in 'mild' hypertension. [1988.04]
Well-designed clinical trials possibly related to Lithium Citrate
Nuclear medicine in the management of thyroid disease. [2008.09]
The co-administration of quetiapine or placebo to cognitive-behavior therapy in treatment refractory depression: a preliminary trial. [2008.08.28]
Impact of remitted substance use disorders on the future course of bipolar I disorder: Findings from a clinical trial. [2008.07.15]
Smoke alarms by type and battery life in rural households: a randomized controlled trial. [2008.07]
Eprosartan modulates the reflex activation of the sympathetic nervous system in sodium restricted healthy humans. [2008.06]
Proton magnetic resonance spectroscopy in youth with severe mood dysregulation. [2008.05.30]
Relationship of open acute mania treatment to blinded maintenance outcome in bipolar I disorder. [2008.04]
Protein kinase C inhibition in the treatment of mania: a double-blind, placebo-controlled trial of tamoxifen. [2008.03]
The effectiveness of mood stabilizers and antiepileptic medication for the management of behaviour problems in adults with intellectual disability: a systematic review. [2008.02]
Effect of intermediate fiber layer on the fracture load and failure mode of maxillary incisors restored with laminate veneers. [2008.01]
Open-label, concomitant use of lamotrigine and other medications for bipolar disorder. [2008.01]
Optimizing treatment outcomes in bipolar disorder under ordinary conditions. [2008]
Renal effects of urodilatin in healthy subjects are independent of blockade of the cyclooxygenase and angiotensin II receptor. [2008]
Data Management and Design Issues in an Unmasked Randomized Trial of Electroconvulsive Therapy for Relapse Prevention of Severe Depression: The Consortium for Research in Electroconvulsive Therapy Trial. [2007.12]
Terlipressin improves renal function in patients with cirrhosis and ascites without hepatorenal syndrome. [2007.12]
Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder. [2007.12]
Cardiovascular effects of enoximone in isoflurane anaesthetized ponies. [2007.11]
Haemodynamic and renal effects of endothelin receptor antagonism in patients with chronic kidney disease. [2007.11]
Agomelatine adjunctive therapy for acute bipolar depression: preliminary open data. [2007.09]
Efficacy of a protein kinase C inhibitor (tamoxifen) in the treatment of acute mania: a pilot study. [2007.09]
DSM melancholic features are unreliable predictors of ECT response: a CORE publication. [2007.09]
Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms: findings from the STEP-BD. [2007.09]
Intensive psychosocial intervention enhances functioning in patients with bipolar depression: results from a 9-month randomized controlled trial. [2007.09]
Facial emotion processing in acutely ill and euthymic patients with pediatric bipolar disorder. [2007.08]
Cost effectiveness of olanzapine in prevention of affective episodes in bipolar disorder in the United Kingdom. [2007.08]
Effect of different all-ceramic crown system on fracture resistance and failure pattern of endodontically treated maxillary premolars restored with and without glass fiber posts. [2007.07]
A clinical comparison of two anaesthetic protocols using lidocaine or medetomidine in horses. [2007.07]
A 24-week, randomized, controlled trial of adjunctive sibutramine versus topiramate in the treatment of weight gain in overweight or obese patients with bipolar disorders. [2007.06]
Effectiveness and weight effects of open-label lamotrigine with and without concomitant psychotropic medications in patients with bipolar I disorder. [2007.05.22]
Quetiapine for acute mania in bipolar disorder. [2007.05.15]
Psychosocial treatments for bipolar depression: a 1-year randomized trial from the systematic treatment enhancement program. [2007.04]
Enhanced sodium retention after acute nitric oxide blockade in mildly sodium loaded patients with essential hypertension. [2007.03]
Influence of luting agent on the microleakage of all-ceramic crowns. [2007.02]
Relapse during continuation pharmacotherapy after acute response to ECT: a comparison of usual care versus protocolized treatment. [2007.01]
A 6-month randomized open-label comparison of continuation of oral atypical antipsychotic therapy or switch to long acting injectable risperidone in patients with bipolar disorder. [2007]
Effects of surface treatment on the microtensile bond strength of ceramic materials to dentin. [2007]
Improvement of insulin sensitivity by metformin treatment does not lower blood pressure of nonobese insulin-resistant hypertensive patients with normal glucose tolerance. [1996.04]
Effects of lovastatin treatment on red blood cell and platelet cation transport. [1991.02]
Epidemiological studies of sodium transport and hypertension. [1987.11]
Other research related to Lithium Citrate
Aripiprazole monotherapy in the treatment of acute bipolar I mania: A randomized, double-blind, placebo- and lithium-controlled study. [2008.10.02]
Adjunctive lithium treatment in the prevention of suicidal behaviour in depressive disorders: a randomised, placebo-controlled, 1-year trial. [2008.09.18]
Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126). [2008.08]
Peroxisome proliferator-activated receptor gamma agonist, rosiglitazone, suppresses CD40 expression and attenuates inflammatory responses after lithium pilocarpine-induced status epilepticus in rats. [2008.08]
Open-label treatment trial of lithium to target the underlying defect in fragile X syndrome. [2008.08]
Stochastic search of the quantum conformational space of small lithium and bimetallic lithium-sodium clusters. [2008.06.26]
[Follow-up of patients that use lithium] [2008.06.12]
Lithium carbonate in the management of cannabis withdrawal in humans: an open-label study. [2008.05.30]
Delirium associated with lithium-quetiapine combination. [2008.05]
Stargazin involvement with bipolar disorder and response to lithium treatment. [2008.05]
The impact of long-term lithium treatment on renal function in an outpatient population. [2008.05]
Adherence to lithium in naturalistic settings: results from a nationwide pharmacoepidemiological study. [2007.11]
Existing condition and migration property of ions in lithium electrolytes with ionic liquid solvent. [2007.10.11]
Spatial distribution of lithium ions in glasses studied by 7Li{6Li} spin echo double resonance. [2007.08.14]
Lithium treatment effects on Myo-inositol in adolescents with bipolar depression. [2006.11.01]
Lithium citrate for Canavan disease. [2005.10]
Glycogen synthase kinase-3: a putative molecular target for lithium mimetic drugs. [2005.07]
High-resolution structure of myo-inositol monophosphatase, the putative target of lithium therapy. [2005.05]
Lithium-induced alterations in nucleoside triphosphate levels in human brain: a proton-decoupled 31P magnetic resonance spectroscopy study. [2005.01.30]
[Lithium] [2004.03]
Chronic lithium treatment of B lymphoblasts from bipolar disorder patients reduces transient receptor potential channel 3 levels. [2004]
Renal, thyroid and parathyroid function during lithium treatment: laboratory tests in 207 people treated for 1-30 years. [1995.01]
Lithium pharmacokinetics in the obese. [1994.04]
The effects of administration of lithium salts and magnesium sulfate on the serum anion gap. [1989.05]
Long-term effects of lithium on the kidney: functional-morphological correlations. [1989]
Other possibly related research studies
Quantitative analysis of monovalent counterion binding to random-sequence, double-stranded DNA using the replacement ion method. [2007.02.20]
Synthesis, DNA affinity, and antiprotozoal activity of linear dications: Terphenyl diamidines and analogues. [2006.08.24]
TPD-based evaluation of near threshold mono-energetic proton energies for the (7)Li(p,n)(7)Be production of neutrons for BNCT. [2006.08.21]
Characterization of moderator assembly dimension for accelerator boron neutron capture therapy of brain tumors using 7Li(p, n) neutrons at proton energy of 2.5 MeV. [2006.06]
Prediction of iontophoretic transport across the skin. [2006.04.10]
|
